BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15372367)

  • 1. Mutation analysis of leukemia inhibitory factor-receptor (LIF-R) in ACTH-secreting pituitary adenomas.
    Heutling D; Dieterich KD; Buchfelder M; Lehnert H
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):458-61. PubMed ID: 15372367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas.
    Hanson JM; Mol JA; Meij BP
    Domest Anim Endocrinol; 2010 May; 38(4):260-71. PubMed ID: 20036483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas.
    Dieterich KD; Gundelfinger ED; Lüdecke DK; Lehnert H
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3327-31. PubMed ID: 9745449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas.
    Hanisch A; Dieterich KD; Dietzmann K; Lüdecke K; Buchfelder M; Fahlbusch R; Lehnert H
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4411-4. PubMed ID: 11095488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
    Oyama K; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical detection and RT-PCR expression of leukaemia inhibitory factor and its receptor in human fetal and adult ovaries.
    Abir R; Fisch B; Jin S; Barnnet M; Freimann S; Van den Hurk R; Feldberg D; Nitke S; Krissi H; Ao A
    Mol Hum Reprod; 2004 May; 10(5):313-9. PubMed ID: 15044601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia inhibitory factor protein and receptors are expressed in the bovine adrenal cortex and increase cortisol and decrease adrenal androgen release.
    Woods AM; McIlmoil CJ; Rankin EN; Packer AA; Stevens JC; Macievic JA; Brown AB; Porter JP; Judd AM
    Domest Anim Endocrinol; 2008 Aug; 35(2):217-30. PubMed ID: 18638665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression by fiber-optic beadarray and pathway in adrenocorticotrophin-secreting pituitary adenomas.
    Jiang ZQ; Gui SB; Zhang YZ
    Chin Med J (Engl); 2010 Dec; 123(23):3455-61. PubMed ID: 22166531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
    Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and pathogenesis of pituitary adenomas.
    Faglia G
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():1-5. PubMed ID: 8396832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
    Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
    Dahia PL; Ahmed-Shuaib A; Jacobs RA; Chew SL; Honegger J; Fahlbusch R; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1996 May; 81(5):1768-71. PubMed ID: 8626831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
    J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor signaling is implicated in embrionic development of the HPA axis.
    Ware CB; Kariagina A; Zonis S; Alon D; Chesnokova V
    FEBS Lett; 2005 Aug; 579(20):4465-9. PubMed ID: 16081071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.